Detalhe da pesquisa
1.
WITHDRAWN: Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease.
Cochrane Database Syst Rev
; (4): CD004569, 2012 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22513924
2.
A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin.
Pediatr Blood Cancer
; 54(2): 284-90, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19927283
3.
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease.
Cochrane Database Syst Rev
; (4): CD004569, 2007 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-17943820
4.
Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1).
J Thorac Oncol
; 6(6): 1006-15, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21532509
5.
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.
J Clin Oncol
; 28(13): 2181-90, 2010 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20351327
6.
Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
J Clin Oncol
; 26(21): 3573-81, 2008 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18640938
7.
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
J Clin Oncol
; 26(21): 3552-9, 2008 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18506026
8.
Operational response to malaria epidemics: are rapid diagnostic tests cost-effective?
Trop Med Int Health
; 11(4): 398-408, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16553923